CSL Executive and Leadership Team

Gordon Naylor, the Interim Chief Executive Officer & Managing Director at CSL, directs the company's overarching strategy and operational execution. Naylor guides CSL's mission to save lives through its diverse portfolio of biotechnology products, including treatments for hemophilia, immune deficiencies, influenza vaccines, and therapies for iron deficiency and nephrology. This leadership role involves steering the organization towards continued innovation and market leadership, ensuring alignment with CSL's long-standing promise to utilize cutting-edge technologies. Gordon Naylor oversees the integration of new advancements and the strategic deployment of resources across global operations, driving the company's commitment to advancing human health and addressing critical medical needs worldwide. The focus remains on maximizing the impact of CSL's lifesaving medicines and therapies.

Julian Lee, the Chief Financial Officer at CSL, directs the company's financial strategy and fiscal management. Lee oversees all financial planning, reporting, and investment activities, ensuring the robust financial health necessary to support CSL's global biotechnology initiatives. This includes managing budgets for the development and distribution of lifesaving medicines for hemophilia, immune deficiencies, influenza vaccines, and therapies for iron deficiency and nephrology. Julian Lee's responsibilities encompass capital allocation, risk management, and driving financial performance to sustain CSL's long-term growth and its promise to save lives through technological advancement. The CFO ensures financial discipline and strategic investment to fuel innovation and expand market access for CSL's critical therapies.

Marcelo Di, the Chief Financial Officer (Brazil) at CSL, leads financial operations and strategic planning within the Brazilian market. Di manages all fiscal activities, including budgeting, forecasting, and financial reporting, to support CSL's lifesaving medicine portfolio in the region, encompassing treatments for hemophilia, immune deficiencies, influenza vaccines, and therapies for iron deficiency and nephrology. This executive ensures financial compliance and optimizes resource allocation to drive growth and operational efficiency in Brazil. Marcelo Di plays a critical part in aligning regional financial strategies with CSL's global promise to save lives through the application of cutting-edge biotechnology. The role involves fostering strong financial performance and supporting market expansion initiatives.

Jody Long, the Administrative Advisor To Chief Financial Officer at CSL, provides critical support and strategic counsel to the Chief Financial Officer, facilitating effective financial management and decision-making. Long assists in overseeing financial planning, reporting, and investment activities that underpin CSL's global biotechnology operations and its portfolio of lifesaving medicines. This role ensures seamless coordination of financial initiatives, supporting the development of treatments for hemophilia, immune deficiencies, influenza vaccines, and therapies for iron deficiency and nephrology. Jody Long contributes to maintaining financial discipline and operational efficiency, reinforcing CSL's promise to save lives using advanced technologies by optimizing resource allocation and strategic financial planning.

Emiliano Chiaramonte, the Chief Financial Officer, LATAM (South) at CSL, directs financial strategy and management for the South Latin America region. Chiaramonte oversees all financial operations, including budgeting, forecasting, and fiscal reporting, to support CSL's lifesaving medicines portfolio within this key market, covering treatments for hemophilia, immune deficiencies, influenza vaccines, and therapies for iron deficiency and nephrology. This executive ensures financial compliance and drives economic performance to bolster CSL's global mission of saving lives through cutting-edge biotechnology. Emiliano Chiaramonte's leadership focuses on optimizing financial resources and supporting strategic growth initiatives across the LATAM (South) territory, reinforcing CSL's commitment to patient access.

Molly Oates, the Chief Operating Officer at CSL, manages the day-to-day operational activities that support CSL's global biotechnology operations. Oates ensures the efficient production and distribution of lifesaving medicines, including those for hemophilia and immune deficiencies, alongside influenza vaccines and therapies for iron deficiency and nephrology. This executive oversees the complex supply chains and manufacturing processes, guaranteeing the consistent delivery of high-quality products. Molly Oates drives operational excellence by optimizing resource allocation and implementing best practices across all facilities, directly contributing to CSL's promise to save lives using the latest technologies. The role involves close collaboration with other C-suite leaders to enhance global reach and operational scalability.

Kye Ehart, the Chief of Staff To the Chief Operating Officer at CSL, enhances operational effectiveness by supporting the Chief Operating Officer in executing strategic initiatives and managing daily operations. Ehart facilitates communication and coordination across departments, ensuring the smooth delivery of CSL's lifesaving medicines, including treatments for hemophilia, immune deficiencies, influenza vaccines, and therapies for iron deficiency and nephrology. This role involves driving operational improvements and ensuring alignment with CSL's core promise to save lives through technological innovation. Kye Ehart plays a key part in optimizing workflows and implementing best practices across global manufacturing and distribution networks, contributing directly to CSL's mission of advancing human health.

Candice Nieves, the Manager Chief Marketing Officer Quality at CSL, oversees the quality assurance and strategic execution of marketing initiatives across CSL's product lines. Nieves ensures that all marketing efforts accurately reflect the value and impact of CSL's lifesaving medicines, including treatments for hemophilia, immune deficiencies, influenza vaccines, and therapies for iron deficiency and nephrology. This role focuses on maintaining brand integrity and compliance with regulatory standards in all promotional activities. Candice Nieves works to enhance market penetration and patient access by developing and implementing high-quality marketing strategies that align with CSL's mission to save lives using advanced technologies. The focus is on delivering clear, impactful messaging to healthcare providers and patients.

Hamza Shanaa, the Manager Chief Marketing Officer Quality at CSL, contributes to the strategic direction and quality control of marketing campaigns for CSL's diverse range of biotechnology products. Shanaa ensures that marketing communications effectively convey the life-saving benefits of CSL's medicines, including those for hemophilia, immune deficiencies, influenza vaccines, and therapies for iron deficiency and nephrology. This position focuses on upholding the highest standards of quality and accuracy in all marketing materials, supporting CSL's commitment to saving lives through technological innovation. Hamza Shanaa collaborates with cross-functional teams to refine messaging and enhance market engagement, ensuring that CSL's promise to deliver advanced therapies is clearly communicated to stakeholders.

Phyllis Post, the Vice President and Chief Information Officer, CSL Behring, Seqirus and Vifor I & T at CSL, directs the information technology strategy and infrastructure across key CSL divisions. Post oversees the implementation and management of technology solutions that support the development, manufacturing, and distribution of lifesaving medicines, including treatments for hemophilia, immune deficiencies, influenza vaccines, and therapies for iron deficiency and nephrology. This leadership role ensures robust cybersecurity, data integrity, and efficient IT operations to advance CSL's mission of saving lives through the latest technologies. Phyllis Post drives digital transformation initiatives, enhancing collaboration and operational efficiency across CSL Behring, Seqirus, and Vifor I & T to meet evolving global healthcare demands.